Prognostic Utility of Right Ventricular Remodeling Over Conventional Risk Stratification in Patients With COVID-19
Jiwon Kim, Alexander Volodarskiy, Razia Sultana, Meridith Pollie, Brian Yum, Lakshmi Nambiar, Romina Tafreshi, Hannah W. Mitlak, Arindam RoyChoudhury, Evelyn M. Horn, Ingrid Hriljac, Nupoor Narula, Sijun Kim, Lishomwa C. Ndhlovu, Parag Goyal, Monika M. Safford, Leslee J. Shaw, Richard B. Devereux, Jonathan W. Weinsaft
Topics & Concepts
MedicineInternal medicineHazard ratioBiomarkerCardiologyAdverse effectConfidence intervalRisk stratificationCoronavirus disease 2019 (COVID-19)Ventricular remodelingClinical endpointHeart failureClinical trialDiseaseInfectious disease (medical specialty)BiochemistryChemistryPulmonary Hypertension Research and TreatmentsCardiovascular Function and Risk FactorsCOVID-19 Clinical Research Studies